News Archives - Page 1152 of 1547

MondayFeb 03, 2020 2:26 pm

NetworkNewsBreaks – Las Vegas Sands Corp. (NYSE: LVS) Featured in ROTH Equity Research Report

Las Vegas Sands Corp. (NYSE: LVS) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “With leverage below 2x, a dividend yield over 5% and continued commitment to return capital to shareholders ($300mm in 4Q19 share repurchases), we believe LVS is better hedged than other Macau stocks as the Coronavirus wreaks havoc on 1Q20 (simultaneously creating likely pent-up demand for BH20). Structurally, we have no change to our Macau or LVS thesis and our CY21 estimates are largely unchanged. However, we acknowledge continued near-term volatility as Macau visitation challenges remain acute.” To…

MondayFeb 03, 2020 2:04 pm

NetworkNewsBreaks – Applied Genetic Technologies Corporation’s (NASDAQ: AGTC) R&D Day Highlights and Insights Featured in ROTH Equity Research Report

Applied Genetic Technologies Corporation (NASDAQ: AGTC) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “On Tuesday we attended AGTC's R&D Day in New York. Management showcased in granular detail data from its XLRP and ACHM clinical programs. In addition, we got to hear from KOLs and patients, and got a sense of their view of what a successful gene therapy would be. With encouraging proof of concept data in hand, and manufacturing in place, AGTC is ready to accelerate development of its XLRP and ACHM programs, and advance its early stage…

MondayFeb 03, 2020 1:42 pm

NetworkNewsBreaks – Syros Pharmaceuticals, Inc.’s (NASDAQ: SYRS) Advancements in CDK Inhibition Featured in ROTH Equity Research Report

Syros Pharmaceuticals (NASDAQ: SYRS) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “Yesterday, Syros announced new preclinical data showcasing the differentiating therapeutic effects of its CDK7 vs CDK12/13 inhibitors. More broadly, the company highlighted its platform's potential to identify genes and transcriptional regulators of cancer, which should enable the identification of new drug targets to further expand its pipeline of small-molecule inhibitors. With this update, coupled with the entry of Syros' next-gen CDK7 inhibitor (SY-5609) into the clinic, we invite you to join our call with a renowned expert on gene…

MondayFeb 03, 2020 1:30 pm

NetworkNewsBreaks – NetworkNewsWire Collaborates with Channelchek-Produced “IPO Podcast Series” to Serve as Official NewsWire

NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company part of the InvestorBrandNetwork (“IBN”), today announced that it will serve as the Official NewsWire in collaboration with the “IPO Podcast Series,” produced by Channelchek. The “IPO Podcast Series,” directed and hosted by Brant Pinvidic, originally a Hollywood producer who pursued his passion for business to become a C-level business consultant, explores the ideas, people and opportunities behind thriving organizations. The series can be found on the Channelchek website, as well as on iTunes and other podcast services. “We are pleased to have the support of NetworkNewsWire as we widen the…

MondayFeb 03, 2020 1:24 pm

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) CEO Featured in Barron’s Article Highlighting Progress of 3-D Printing Industry

Sigma Labs Inc. (NASDAQ: SGLB) CEO John Rice was featured in an article published Monday by Barron’s. The article, titled ‘3-D Printing Is Making Gains in Unexpected Places, Like Cars and Artificial Knees’, evaluates the advancement of 3-D printing, or additive manufacturing, in a number of diverse industries, including automotive production and health care. Rice commented on the process of 3-D metal printing, which leverages focused light to build complex shapes with metal powder. “In effect you make a giant welded part,” Rice told Barron’s. Sigma is servicing the industry by marketing products designed to improve the quality and expedite…

MondayFeb 03, 2020 1:00 pm

NetworkNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Prevails in Long-Lasting Lawsuit with New York Lender

LiveWire Ergogenics Inc. (OTC: LVVV), a health and wellness company with a focus on special purpose real-estate acquisitions and the licensing and management of high-end and permitted facilities and operations to provide cannabis-based products and services in California, announced that it has prevailed in a long-lasting lawsuit with America E Group. According to the update, United States District Court Judge Gregory H. Woods of the United States District Court for the Southern District of New York on January 28, 2020, issued an opinion and order in the action entitled, American E Group LLC v. Livewire Ergogenics Inc. (18-civ-3969) that granted…

MondayFeb 03, 2020 12:18 pm

NetworkNewsBreaks – Global Water Resources, Inc. (NASDAQ: GWRS) Secures $12.5 Million in Underwritten Public Offering

Global Water Resources (NASDAQ: GWRS), a pure-play water resource management company, has closed an underwritten public offering of 1,000,000 shares of its common stock, which includes 130,000 additional shares pursuant to the full exercise of the over-allotment option granted to the underwriters. According to the update, Global Water Resources secured approximately $12.5 million in gross proceeds from the offering in which each of the shares were sold at the public offering price of $12.50. The company anticipates using the proceeds to fund acquisitions and for working capital and other general corporate purposes. ROTH Capital Partners acted as sole manager for…

MondayFeb 03, 2020 11:26 am

NetworkNewsBreaks – Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) Announces Upsizing of Financing, Working Capital to Continue Progress on Growth Objectives and Expansion Efforts

Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF), a globally-focused, multi-state cannabis and hemp operator, today announced the receipt of $35.65 million in proceeds and $9.56m of exchanged debt in connection with the Company's previously announced debt financing. "We are pleased with the upsizing of our financing providing working capital that will allow Jushi to continue making progress on its growth objectives and expansion efforts into 2020 and beyond,” Jushi Chairman and CEO Jim Cacioppo said in the news release. “This capital will support our continued investment in each territory we are currently operating in, positioning Jushi to achieve US$200 to $250…

MondayFeb 03, 2020 10:56 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at NobleCon16 Investor Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that it will present at the Noble Capital Markets 16th Annual Investor Conference. Genprex’s presentation is scheduled to take place at 1:30 p.m. EST on Monday, February 17, 2020, at the conference to be held at the Seminole Hard Rock Hotel & Casino in Hollywood, Florida from February 16-18, 2020. According to the update, Genprex CEO Rodney Varner will deliver an overview of the Company and provide updates on its product pipeline, including the Food…

MondayFeb 03, 2020 10:23 am

NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Appoints Cannabis Industry Veteran Robert L. Hymers III as its Chief Financial Officer

MCTC Holdings (OTC: MCTC), a cannabinoid science forward company developing unique hemp infusion technologies, today announced its addition of cannabis industry veteran, Robert L. Hymers III, as its chief financial officer. Hymers, who currently serves as a director of the Company, brings an extensive background in corporate finance, treasury, financial planning and analysis, tax, investor relations, strategic planning and risk management along with a deep understanding of the hemp and cannabis industries. "The addition of Robert Hymers to the management team significantly strengthens our Company,” MCTC Chief Executive Officer Arman Tabatabei said in the news release. “He brings a unique…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Breaks Categories: News